Recombinant Varicella-zoster virus gE protein, N-His, Biotin Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bs-42275P-Biotin-100ug |
| Product Name | Recombinant Varicella-zoster virus gE protein, N-His, Biotin Conjugated |
| Applications | Others |
| Reactivity | Others |
| Specifications | |
| Conjugation | Biotin |
| Source | Recombinant Varicella-zoster virus gE protein is expressed in E.coli with N-His. It contains the amino acid sequence of 31-538/623 |
| Storage Buffer | Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization. |
| Target | |
| Swiss Prot | Q9J3M8 |
| Background | Varicella Zoster Virus (VZV), a member of the human herpes virus family, causes two distinct clinical manifestations: childhood chickenpox(Varicella) and shingles (zoster). Varicella is the outcome of the primary infection with VZV, whereas, zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals. VZV virons are spherical and 150-200 nm in diameter. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. Its DNA is a single linear, double strand molecule, 125,000 nt long. |
Powered by Bioz